CSA Medical Completes $20.5 Million Series B Financing
Funds to Support Post-Market Clinical Studies and New Indications for Spray Cryotherapy Technology CSA Medical, Inc., the leading developer of novel Spray Cryotherapy devices that
We are proud of the moves our companies are making, and share select news stories about our current portfolio companies. We also write about our thinking in the space, and often find ourselves in the news, or on podcasts.
Funds to Support Post-Market Clinical Studies and New Indications for Spray Cryotherapy Technology CSA Medical, Inc., the leading developer of novel Spray Cryotherapy devices that
Our portfolio companies spend every day removing obstacles and working to overcome challenges students and workers have to get a good education and a good job.
Get all the latest news and updates.